Inventor
SUN LI-QIANG
US46 patents
⚠️ This page may combine multiple inventors who share the name “SUN LI-QIANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
39 patentsUS7449479B2Nov 11, 2008
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO67 citations99
US6995174B2Feb 7, 2006
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO194 citations98
US7135462B2Nov 14, 2006
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO72 citations97
US9308236B2Apr 12, 2016
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
BRISTOL MYERS SQUIBB CO51 citations96
US7915291B2Mar 29, 2011
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO40 citations96
US9879046B2Jan 30, 2018
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
BRISTOL MYERS SQUIBB CO17 citations93
US8710229B2Apr 29, 2014
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO10 citations92
US7045551B2May 16, 2006
1-aryl-2-hydroxyethyl amides as potassium channel openers
BRISTOL MYERS SQUIBB CO35 citations92
US10143746B2Dec 4, 2018
Immunomodulators
BRISTOL MYERS SQUIBB CO9 citations84
US9944678B2Apr 17, 2018
Immunomodulators
BRISTOL MYERS SQUIBB CO8 citations84
US9732119B2Aug 15, 2017
Immunomodulators
BRISTOL MYERS SQUIBB CO14 citations84
US9227940B2Jan 5, 2016
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO3 citations84
US7772180B2Aug 10, 2010
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO17 citations84
US10538555B2Jan 21, 2020
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
BRISTOL MYERS SQUIBB CO8 citations83
US9850283B2Dec 26, 2017
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
BRISTOL MYERS SQUIBB CO12 citations82
US8889871B2Nov 18, 2014
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO3 citations74
US6900210B2May 31, 2005
Pyridinyl, pyrimidinyl and pyrazinyl amides as potassium channel openers
BRISTOL MYERS SQUIBB CO7 citations74
US10358463B2Jul 23, 2019
Immunomodulators
BRISTOL MYERS SQUIBB CO7 citations73
US10144706B2Dec 4, 2018
Compounds useful as immunomodulators
BRISTOL MYERS SQUIBB CO7 citations73
US8697706B2Apr 15, 2014
Compounds for the treatment of hepatitis C
BRISTOL MYERS SQUIBB CO4 citations73
US8629150B2Jan 14, 2014
Compounds for the treatment of hepatitis C
BRISTOL MYERS SQUIBB CO4 citations73
US10882844B2Jan 5, 2021
Compounds useful as immunomodulators
BRISTOL MYERS SQUIBB CO4 citations72
US10450347B2Oct 22, 2019
Immunomodulators
BRISTOL MYERS SQUIBB CO6 citations72
US9636375B2May 2, 2017
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO1 citations63
US7935670B2May 3, 2011
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO2 citations63
US7087609B2Aug 8, 2006
3-(pyridinyl-piperazin-1-yl)-phenylethyl amides as potassium channel openers
BRISTOL MYERS SQUIBB CO5 citations63
US11066445B2Jul 20, 2021
Immunomodulators acting as antagonists of PD-1
BRISTOL MYERS SQUIBB CO2 citations62
US10745382B2Aug 18, 2020
Compounds useful as immunomodulators
BRISTOL MYERS SQUIBB CO2 citations62
US7592336B2Sep 22, 2009
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO4 citations62
US7144881B2Dec 5, 2006
Arylcyclopropylcarboxylic amides as potassium channel openers
BRISTOL MYERS SQUIBB CO5 citations62
US6630469B2Oct 7, 2003
5-HT7 receptor antagonists
BRISTOL MYERS SQUIBB CO3 citations62
US6737431B2May 18, 2004
Benzoxazole derivatives as novel melatonergic agents
BRISTOL MYERS SQUIBB CO3 citations61
US9527885B2Dec 27, 2016
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO1 citations50
US9624245B2Apr 18, 2017
Macrocyclic compounds as HCV entry inhibitors
BRISTOL MYERS SQUIBB CO0 citations42
US9409943B2Aug 9, 2016
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO0 citations42
US7601686B2Oct 13, 2009
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO0 citations42
US9598433B2Mar 21, 2017
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO0 citations41
US9643999B2May 9, 2017
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO0 citations40
US9499550B2Nov 22, 2016
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO0 citations39
WANG TAO
4 patentsUS8586584B2Nov 19, 2013
Compounds for the treatment of hepatitis C
WANG TAO7 citations84
US8445490B2May 21, 2013
Compounds for the treatment of hepatitis C
WANG TAO11 citations84
US8933066B2Jan 13, 2015
Compounds for the treatment of hepatitis C
WANG TAO4 citations73
US8741884B2Jun 3, 2014
Compounds for the treatment of hepatitis C
WANG TAO4 citations73